QuVa Pharma, Inc.: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125%
Recall reason: Lack of Assurance of Sterility. Recalled by QuVa Pharma, Inc.. Distribution: U.S. Nationwide. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot, expiry: Lots 10140284, 10140285, 10140315, 10140316, exp 04/08/2025; Lot 10140510, exp 04/14/2025; Lot 10140916, e. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report